At DNA Labs UAE, we understand the critical importance of accurate and timely diagnosis for patients with suspected acute lymphoblastic leukemia (ALL). One of the advanced diagnostic tests we offer is the TEL/AML1 (ETV6-RUNX1) test, which is crucial for identifying specific genetic abnormalities associated with ALL. This article aims to provide comprehensive information on the symptoms of ALL that may prompt the TEL/AML1 test, the significance of this test in the diagnosis and management of ALL, and details regarding the test cost and procedure.
Symptoms Leading to the TEL/AML1 ALL Test
Acute lymphoblastic leukemia (ALL) is a type of cancer that affects the blood and bone marrow and is characterized by the overproduction of immature white blood cells, known as lymphoblasts. The TEL/AML1 test is particularly important for diagnosing cases of ALL that involve a specific chromosomal abnormality. Recognizing the symptoms that may indicate ALL is crucial for timely diagnosis and treatment. These symptoms include:
- Persistent fatigue and weakness
- Fever or night sweats
- Frequent infections
- Bruising or bleeding easily
- Pain in the bones or joints
- Swollen lymph nodes
- Unexplained weight loss
While these symptoms can be associated with various health conditions, their persistence or severity may prompt further investigation, including the TEL/AML1 ALL test, to rule out or confirm ALL.
Significance of the TEL/AML1 ALL Test
The TEL/AML1 test plays a pivotal role in the diagnosis of ALL by detecting the presence of the TEL/AML1 gene fusion. This genetic abnormality results from the translocation between chromosomes 12 and 21 and is associated with a subtype of ALL that typically has a favorable prognosis. Identifying this genetic marker can significantly influence treatment decisions and patient management. The test is performed on a blood or bone marrow sample, utilizing sophisticated molecular techniques to detect the specific genetic rearrangement.
Test Cost and Procedure
The cost of the TEL/AML1 ALL test at DNA Labs UAE is 1050 AED. This price includes the collection of the sample, the laboratory analysis, and a comprehensive report detailing the test results. The procedure for the test involves the collection of a blood sample or, in some cases, a bone marrow sample. The sample is then processed in our state-of-the-art laboratory, where our team of experts conducts the molecular analysis to detect the presence of the TEL/AML1 fusion gene.
It is important for patients to consult with their healthcare provider to understand the implications of the test results and how they may impact treatment options. Our team at DNA Labs UAE is committed to providing support and guidance throughout the testing process and ensuring that patients and healthcare providers receive accurate and actionable information.
Conclusion
The TEL/AML1 ALL test is a critical tool in the diagnosis and management of acute lymphoblastic leukemia, offering hope for a targeted treatment approach. Recognizing the symptoms that may indicate the need for this test is the first step towards a timely and accurate diagnosis. At DNA Labs UAE, we are dedicated to providing advanced diagnostic solutions, including the TEL/AML1 ALL test, to support patients and healthcare providers in the fight against leukemia. For more information or to schedule a test, please visit our website at https://dnalabsuae.com/tests/telaml-all-test/.
